Lung Cancer Therapy Market Share, Size, and Trends by 2030
Lung Cancer Therapy Market: Strategic Insights
Lung Cancer Therapy Market
-
CAGR (2022 - 2030)12.7% -
Market Size 2022
US$ 31.02 Billion -
Market Size 2030
US$ 80.49 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Cases of Lung Cancer
- Government Initiatives for Screening and Treatment of Lung Cancer
FUTURE TRENDS
- Growing Demand for Targeted Therapy
OPPORTUNITIES
- Rising Number of Lung Cancer Therapy in Clinical Trials
Key Players
- Medtronic PLC
- RF Medical Co Ltd
- Johnson Johnson
- Merck KGaA
- Sun Pharmaceutical Industries Ltd
- Bioventus Inc
- Meiji Seika Pharma Co Ltd
- Advanz Pharma Corp
- Olympus Corp
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Therapy Type
- Noninvasive and Minimally Invasive
Indication
- Non-Small Cell Lung Cancer and Small Cell Lung Cancer
End User
- Hospitals
- Oncology Clinics
- Research Centers